Peter Warendorf

Stock Analyst at Barclays

(4.19)
# 1,532
Out of 4,996 analysts
43
Total ratings
77.8%
Success rate
22.2%
Average return

Stocks Rated by Peter Warendorf

HealthEquity
Sep 18, 2026
Reiterated: Buy
Price Target: $110 → $115
Current: $90.39
Upside: +27.23%
LifeStance Health Group
Sep 10, 2026
Reiterated: Buy
Price Target: $13 → $15
Current: $12.09
Upside: +24.12%
Progyny
Aug 12, 2026
Reiterated: Hold
Price Target: $34 → $30
Current: $25.83
Upside: +16.14%
Teladoc Health
Aug 3, 2026
Reiterated: Hold
Price Target: $7
Current: $6.13
Upside: +14.19%